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Abstract The secondary structure and global fold of the AVR9 
elicitor protein of Cladosporium fulvum has been determined by 
2D NMR and distance-geometry protocols. The protein consists 
of three anti-parallel strands forming a rigid region of P-sheet. 
On the basis of the NMR-derived parameters and distance 
geometry calculations, it is evident that the AVR9 protein is 
structurally very homologuous to carboxy peptidase inhibitor 
(CPI) of which the X-ray structure is known. The AVR9 protein 
reveals the presence of a cystine knot, which consists of a ring 
formed by two disulfide bridges and the interconnecting back-
bone through which the third disulfide bridge penetrates. This 
structural motif is found in several small proteins such as 
proteinase inhibitors, ion channel blockers and growth factors. 
The implications of the structural relationship between AVR9 
and other biologically active proteins are discussed. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Plant pathogens produce various types of molecules which 
play crucial roles in the interaction with their host plants. 
They include pathogenicity factors such as enzymes degrading 
plant cuticle and plant cell walls, enzymes degrading antimi-
crobial plant compounds and low molecular weight toxins 
that kill plant cells [1]. Pathogens also secrete molecules, the 
so-called elicitors, that induce active defense responses in their 
hosts [2]. Elicitors are divided into non-specific and race-spe-
cific elicitors. Non-specific elicitors induce a defense response 
in plants irrespective whether these plants are resistant or 
susceptible to the pathogen from which the elicitor is ob-
tained. Non-specific elicitors can be proteins or glycoproteins 
[3], oligosaccharins or oligochitins [4—6]. Race-specific elicitors 
are compounds that only induce defense responses in geno-
types of host plants which are resistant to the pathogenic race 
that produces the elicitor, but not in susceptible genotypes. 
Three fungal race-specific elicitors have been isolated so far. 
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NIP1 is a race-specific protein elicitor from the barley patho-
gen Rhynchosporium secalis [7]. It is a 82 amino acid protein 
that specifically induces the accumulation of PR Hv-1, a 
pathogenesis-related protein of barley. AVR4 and AVR9, 
are race-specific protein elicitors containing 106 and 28 amino 
acid residues, respectively, produced by strains of the fungal 
tomato pathogen Cladosporium fulvum, which induce a hyper-
sensitive response (HR) in tomato genotypes carrying the 
complementary genes for resistance Cf-4 and Cf-9, respec-
tively [2,8]. The primary structure of these two race-specific 
elicitor proteins (AVR4 and AVR9) is known and their encod-
ing avirulence genes (Avr4 and Avr9) have been cloned [9,10]. 
The resistance gene Cf-9 from tomato, complimentary to 
AVR9, has been cloned [11]. 
Neither the secondary nor the tertiary structure of the gene 
products of fungal avirulence genes and corresponding plant 
resistance genes are known. Many of the cloned plant resist-
ance genes show sequence homology, of which the most strik-
ing property is the occurrence of leucine-rich repeats in their 
gene products [11-19]. The only leucine-rich protein of which 
the crystal structure has been determined is porcine ribonu-
clease inhibitor [20-22]. About the physical interaction be-
tween fungal avirulence gene products (the race-specific elic-
itors) and resistance gene products nothing is known yet. The 
three characterized fungal race-specific elicitor proteins are 
small molecules of which the structure could be determined 
by 1H NMR provided sufficient amounts of the proteins are 
available. NIP1 is a race-specific elicitor which is constitu-
tively produced in vitro, while both AVR4 and AVR9 race-
specific elicitor proteins are only produced by C. fulvum in 
planta. In addition, the Avr9 gene of C. fulvum can be induced 
in vitro under nitrogen-limiting growth conditions [23]. The 
gene encodes a pre-pro-protein of 63 amino acids, containing 
a signal protein of 23 amino acids, resulting in a protein of 40 
amino acids which is processed by fungal and/or plant pro-
teases into a mature protein of 28 amino acids. The mature 28 
amino acid protein, found in infected plants, induces HR in 
Cf-9 genotypes [24]. By replacing the promoter of the Avr9 
gene by the constitutive glyceraldehyde-3-phosphate dehydro-
genase (gpd) promoter of the fungus Aspergillus nidulans, the 
AVR9 protein can be produced in significant amounts. C 
fulvum transgenic for Avr9 secretes the AVR9 protein in vitro 
into the culture medium [24]. However, in vitro not the ma-
ture protein of 28 amino acids is produced, but rather a mix-
ture of proteins containing 32, 33 or 34 amino acids. The 
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biological activity of these proteins is indistinguishable from 
the mature 28 amino acid protein. 
Here we report on the secondary structure and global fold 
of the in vitro produced 33 amino acid AVR9 race-specific 
elicitor as determined by XH N M R . The AVR9 protein has a 
structural motif consisting of a cystine knot and a small triple-
stranded antiparallel P-sheet. These motifs are common in 
proteinase inhibitor proteins [25], ion channel blocker proteins 
[26] and various hormonal growth factors [27]. Structurally 
the AVR9 protein is most related to the carboxypeptidase 
inhibitor protein of pota to . 
2. Materials and methods 
2.1. Production and purification of AVR9 elicitor 
To produce sufficient quantities of the AVR9 elicitor in vitro the 
promoter of the Avr9 gene has been replaced by the constitutive 
promoter of the glyceraldehyde-3-phosphate dehydrogenase (gpd) 
gene of Aspergillus nidulans and the resulted construct was introduced 
into race 5 of C. fulvum by transformation [24], The transgemc race of 
C. fulvum secretes a mixture of 32, 33 and 34 amino acid AVR9 
proteins into the culture medium. The transgenic race was grown in 
B5 medium for 2 weeks and the proteins were isolated according to 
the methods desribed before [24]. Using this protocol 2 mg of the 33 
amino acid AVR9 protein was purified. The purity of A"VR9 was 
checked by analytical high-performance column chromatography as 
described before [24]. The molecular mass of the purified AVR9 pro-
tein was verified by electrospray mass spectrometry (TSQ-70 mass 
spectrometer with Finnigan Mat interface). The atomic mass of the 
protein was determined to be 3629.2 ± 1.5 Da. From the atomic mass 
it can be concluded that three disulfide bonds are present in the AVR9 
protein. The presence of three disulfide bonds has also been confirmed 
by electrospray mass spectrometry measurements of the 28 amino acid 
AVR9 protein where an atomic mass of 3188.5 ± 1.4 Da was found. 
2.2. NMR measurements 
Protein concentrations used for NMR experiments were 1 mM in 
90% H2O/10% D 2 0 , pH 5. NMR spectra were recorded on a Bruker 
AMX 500 and a Bruker AMX 600 spectrometer. All 2D-NMR spec-
tra were recorded in the pure phase absorption mode using time-
proportional phase incrementation (TPPI) [28]. Nuclear Overhauser 
effect spetroscopy (NOESY) spectra were recorded at 298 K and at 
280 K with mixing times of 175, 250 and 500 ms. Clean total corre-
lation spectroscopy (TOCSY) spectra [29] were recorded with the 
MLEV spinlocking sequences in H2O and D2O at 298 K with spin 
lock times of 60 and 85 ms. The water signal was suppressed using 
low power presaturation on the water frequency. In most experiments 
the stimulated crosspeaks under bleached alphas (SCUBA) sequence 
[30] was incorporated using a SCUBA delay of 40 ms to recover 
saturated resonances under the solvent peak. All homonuclear 2D 
spectra were recorded with 512 ti increments with 4096 data points 
and a spectral width of 6042 Hz at 500 MHz. 1H chemical shifts are 
referenced at the HDO resonance at 298 K and pH 5 at 4.77 ppm [31]. 
All 1H NMR chemical shifts are collected in Table 1. 
Distance restrains were collected from the NOESY spectra with 250 
ms mixing time. The NOESY peaks were compared with those in the 
175 and 500 ms mixitng time spectra in order to correct for spin-
diffusion. The NOESY peaks were divided into three categories: 
weak (1.8-5.0 A), medium (1.8-3.5 A) and strong (1.8-2.7 A). Slowly 
exchanging amides were determined from the NH resonances (both on 
the diagonal as from the fingerprint region crosspeaks) present in 
NOESY spectra recorded at 298 K in D 2 0 of a AVR9 sample which 
was previously fully protonated and lyophilized. The spectra were 
recorded within the first 12 h of exchange and several days after 
dissolving the AVR9 sample in D2O. In this way intermediate and 
slowly exchanging protons could be determined. It is assumed that the 
slowly exchanging NH protons form strong hydrogen bonds within 
the structure thereby decreasing the exchange rate of these protons. 
All slowly exchange amide protons form part of a p-sheet as evi-
denced by the intra-residue, sequential and inter-strand NOEs. 
NMR spectra were processed on a Bruker X32 work station using 
UXNMR software or on a Silicon Graphics Indigo2 work station, 
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using Felix 2.3. The free induction decays were zero-filled and multi-
plied by appropriately matched sine bell functions prior to Fourier 
transformation. Backbone 3JHN-H<X coupling constants were measured 
from DQF-COSY spectra in H 2 0 zero-filled to 1KX8K data points 
(digital resolution in the F2-dimension is 0.8 Hz/point). 
The J-couplings were combined with the NOE intensities between 
the [3-methylene protons and the H a or the NH protons to allow 
stereospecific assignments of the P and P' protons. Using these stereo-
specific assignments dihedral angle constrains were deduced as either 
gauche+, gauche - or trans. 
Structure determination was performed on a Silicon Graphics 
Indigo2 work station using the Biosym software package, which in-
cludes DGII [32] for distance geometry and Discover for energy min-
imization and molecular dynamics. A series of structures was con-
structed using DGII and simulated annealing using 254 distance 
restraints and 26 dihedral restraints (]11 cp> and 15 %). The rather low 
concentration of protein prohibited the determination of a larger 
number of NOE derived distance restraints. A total of 20 structures 
were calculated using disulfide bonds between cysteine residues 7-21, 
11-24 and 17-31. The average structure was energy-minimized using 
Discover. 
3. Results 
3.1. NMR assignments 
The resonances of amide region are well dispersed, indica-
tive of a well-defined structure. Moreover, the splitting of the 
H N resonance resulting from the 3JHN-HCI coupling can be 
determined directly from the I D XH N M R spectrum. The 
resonances shown could be assigned from DQF-COSY, N O -
ESY and TOCSY spectra in H 2 0 and D 2 0 . 
The protein contains 17 A M X spin systems, four glycine 
A X systems, two AM(PT)X glutamine spin systems, three 
leucines, two valines, two arginines and one lysine, threonine 
and alanine, respectively. All 17 A M X spin systems can be 
found in the TOCSY spectrum in H2O. Of the four glycine 
residues the resonances of G l and G3 could not be found in 
the TOCSY spectra in H2O, indicating fast exchange of their 
amide protons. Of the other spin systems all amide protons 
could be found, except for the amide proton of L4. Remark-
able is the weak contact between the H4 protons of the two 
histidine residues and their C(3-methylene protons. The pres-
ence of these two crosspeaks unambiguously establishes the 
spin system identification of the two histidines H27 and H33. 
On exchange of H2O for D 2 0 several amide protons do 
not , or hardly, exchange in a time frame of days. F r o m com-
parison of the N O E S Y data sets in H 2 0 and in D 2 0 it be-
came immediately clear that the residues, of which the amide 
protons do not exchange, are all located in a P-sheet with 
antiparallel strands as strong Haj -HNi+i and H a - H a con-
tacts were observed in the spectra. 
Sequential assignments are obtained according to standard 
procedures [33] and were primarily based on the 2 D ^ - N O -
ESY spectra in H 2 0 and D 2 0 . Most residues in the antipar-
allel p-sheets were readily identified by the strong sequential 
d a N crosspeaks in the N O E S Y spectra. The three strands of 
p-sheet are shown in Fig. 1. The three strong H a - H a contacts 
indicated in this figure are prominently present in the D 2 0 
N O E S Y spectra. Some residues were more difficult to assign 
(not located in the P-sheet region) as they showed overlap for 
their amide proton resonance and having only a limited num-
ber of N O E S Y crosspeaks. However, by detailed comparison 
of spectra obtained at 280 and 297 K these ambiguities could 
be solved. N o inter-residual N O E connectivities could be de-
termined for the first four amino acid residues of the AVR9 
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Fig. 1. p-sheet pleated structure, consisting of three anti-parallel strands, of the 33 amino acid AVR9 protein. Hydrogen bonds are indicated 
by dotted lines. Strong Ha-Ha NOE contacts are indicated by arrows. The loop of F26-L29 is a type-I turn. 
protein, suggesting that these residues do not have a well-
ordered character and are flexible. 
The presence of strong sequential HN-HN contacts be-
tween Q30 and L29 suggests that the beginning of the third 
and last strand of the p-sheet is twisted at residue L29. The 
Table 1 
XH chemical shifts" of AVR9 at pH 5 and 298 K 
Residue HN a 
Gly1 
Val2 
Gly3 
Leu4 
Asp5 
Tyr6 
Cys7 
Asn8 
Ser9 
Ser10 
Cys11 
Thr12 
Arg13 
Ala14 
Phe15 
Asp16 
Cys17 
Leu18 
Gly19 
Gin20 
Cys21 
Gly22 
Arg23 
Cys24 
Asp25 
Phe26 
His27 
Lys28 
Leu29 
Gin30 
Cys31 
Val32 
His33 
n.o. n.o. 
8.52 4.25 
n.o. n.o. 
n.o. 4.52 
7.42 4.67 
8.75 4.52 
8.31 4.31 
8.89 4.56 
8.17 4.59 
8.57 4.96 
7.80 4.93 
8.64 4.50 
7.93 4.73 
9.18 4.02 
7.21 4.62 
7.43 4.63 
8.47 4.77 
8.33 4.38 
8.46 4.02, 
8.67 4.23 
8.25 4.35 
7.48 3.59, 
8.35 4.59 
8.79 4.69 
8.42 4.50 
8.32 4.25 
8.63 4.67 
7.81 4.25 
8.57 3.93 
7.12 5.19 
8.58 5.27 
9.63 4.77 
8.42 4.82 
P 
2.16 
1.37, 
3.63, 
3.45, 
3.16, 
3.01, 
4.02, 
4.01, 
3.36, 
4.39 
1.67, 
1.47 
3.22, 
3.13, 
2.97, 
1.54, 
3.79 
2.15, 
2.96, 
3.51 
1.59, 
2.51, 
3.09, 
3.29, 
3.45, 
1.89, 
2.09, 
1.79, 
3.31, 
2.44 
3.22, 
1.37 
2.19 
3.17 
3.06 
3.01 
3.99 
3.93 
3.03 
1.37 
3.09 
2.97 
2.80 
1.54 
2.15 
2.72 
1.59 
2.04 
2.62 
Others 
Y 0.99, 0.99 
Y 1.15; 8 1.27, 0.76 
8 7.30; e 6.87 
Y 1.23 
Y 1.67, 1.52; 8 3.27, 3.19; e 7.31 
8 7.21; e7.37; C, 7.27 
Y 1.62; 8 0.93,0.87 
Y 2.49, 2.49 
Y 1.45, 1.27; 8 3.19, 3.12; e 7.35 
2.80 8 7.16; e 7.37; C, 7.27 
3.45 
1.52 
1.97 
1.59 
3.25 
3.22 
H2 8.67; H4 7.39 
Y 1.42; 8 1.63; e 2.99; C, 7.61 
Y 1.53; 8 1.02, 0.97 
Y2.28, 2.18 
Y 0.96, 0.83 
H2 8.68; H4 7.42 
"Proton chemical shifts are referenced to H2O at 4.77 ppm. 
n.o., not observed. 
connectivity pattern of the loop from residue F26-L29 has all 
characteristics of a type-I turn. The strong H a - H a contact 
between H33 of the (3-sheet and an AMX spin system shows 
that the second strand of the P-sheet has a P-bulge at residue 
G22. The hydrogen bond pattern is indicated in Fig. 1 and 
matches the slow exchange rates of the amide protons of Cl 1, 
D25, L29, Q30, C31 and V32. These protons do not exchange 
within a time frame of days when the protein is dissolved in 
D 2 0 . The amide proton of R23 has an intermediate exchange; 
this proton is only present in NOESY spectra taken within 8 h 
after dissolving the protein in D2O. R23 is the only residue of 
which the amide proton shows intermediate exchange. The 
amide protons of the residues S9, S10, C21, G22, C24, F26, 
H27, K28 and H33 do exchange fast with solvent which is 
consistent with the hydrogen bonding pattern as indicated in 
Fig. 1. 
The residues D5-N8 and T12-Q20 do not show any regular 
secondary structure, although some HN-HN NOE contacts 
can be observed, possibly indicating some a-helical character. 
However, several long-range NOE contacts can be observed in 
the NOESY spectra, showing that these regions have a clear 
structural character. In contrast, the residues G1-L4 which 
have no long-range NOE-contacts are not well ordered. 
The residues T12, R13, A14, F15 and D16 are strongly 
influenced by temperature and pH as the amide protons of 
these residues can shift up to 0.1 ppm depending on the con-
ditions, indicating that these regions can undergo small struc-
tural fluctuations based on the environment. 
4. Discussion 
The structure of the 33 amino acid AVR9 protein consists 
of a compact sulfur core, three strands of antiparallel P-sheet 
formed by the residues S9-C11, R23-F26 and L29-H33, a very 
floppy region G1-L4 and a large extended loop region T12-
Q20. It is evident from the electro spray mass spec, results 
that AVR9 contains three disulfide bonds. The structures of 
numerous small cysteine-rich proteins including serine pro-
teinase inhibitors [25], ion channel blockers [26] and growth 
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CgTx GVIA 
Kalata B 
CMT1-I 
EETI-II 
CPI 
AVR9 
C-KSZGSSCSZTSYNC CRSCNZYT 
INGLPVC GETCV-GGT-C-NTPGC-TCSW 
RVC-PRILMECKK-DSDCL-AE-C-VCLEH-
GC-PRIEMRCKO-DSDCL-AG-C-VCGPN-
EQHADPIC NKPCKTHD-DCSGAWFCOACW NSARTCGPYVG 
GVGLDYC NSSCTRAF-DCLGQ- -CG££D- - -FHKLOCVH 
Fig. 2. Polypeptide sequences aligned on the basis of half-cystine positions and P-strand (underlined) hydrogen bonding patterns [25]. AVR9 is 
included in the alignment. Half-cystines are in bold. 
factors [27] have been studied in recent years by XH NMR or 
X-ray crystallography. However, although 2H NMR assign-
ments can be obtained, defining the definitive 3D structure 
can still be quite tedious due to the large number of cysteine 
residues potentially forming disulfide bonds. These disulfide 
bonds provide great stability to these proteins. Structurally 
these proteins are very much related [25]. Fig. 2 shows the 
primary structure and P-strands of various cysteine-rich pro-
teins studied by *H NMR, including coCgTx GVIA [34], Ka-
lata Bl [35], Cucurbita maxima trypsin inhibitor (CMTI-I; 
[36]), Ecballium elaterium trypsin inhibitor (EETI-II; [37]), 
carboxy peptidase inhibitor (CPI; [38]) and C. fulvum AVR9 
(this article). On the basis of the secondary structure elements 
and the 1H chemical shifts it became evident that the AVR9 
protein has much in common with this class of proteins. All 
proteins show the same structural organization with three 
strands forming an antiparallel pleated P-sheet. Moreover, 
amide protons of residues located in the same position in 
the P-sheet show the same exchange behaviour. The strong 
resemblance in HN and Ha chemical shifts between AVR9 
and CPI [38] is striking, the more so as the homology in 
amino acid sequence is very limited. 
In the 3D structure of CPI, EETI-II and coCgTx GVIA1 the 
disulfide bonds are between residues C1-C4, C2-C5 and C3-
C6, where Cl is the first cysteine residue at the N-terminus. 
Moreover, the 3D X-ray structure of the enzyme-inhibitor 
complex of carboxypeptidase A and CPI is reported [39]. 
Also recently the X-ray structure of EETI-II has been deter-
minded and shown to have identical disulfide bonds as in-
ferred from the NMR study (Le Nguyen, [37] and pers. 
comm.). Based on these data we calculated the 3D structure 
of the AVR9 protein using disulfide bonds between C l -
C4(=C7-C21), C2-C5 (=C11-C24) and C3-C6 (=C17-C31) 
residues. After DGII calculations, a set of 20 structures was 
obtained of which three were discarded as they showed the 
largest NOE violations. The RMSD over the backbone atoms 
of the remaining 17 structures was 1.4 A. 
A common property of the reported proteins and growth 
factors is the presence of the so-called cystine knot [25,40,41]. 
The superfamily of cystine knot-containing molecules has 
been divided in two classes: the inhibitor cystine knots [25] 
and growth factor cystine knots [40,41]. The proteins belong-
ing to the inhibitor cystine knots show large structural sim-
ilarity over motif residues forming the cystine knot. The ami-
no acid residues making up this motif are located in a triple-
stranded, anti-parallel p-sheet which consists of a minimum of 
10 residues, XXC2, XC5X, XXC6X (where the numbers on 
the half-cystine residues refer to their positions in the disulfide 
pattern). The cystine knot consists of a ring formed by cys-
tines C1-C4, C2-C5 and the intervening protein backbone, 
through which the third disulfide (C3-C6) passes. On align-
ment of an energy minimized structure of the AVR9 protein 
with the structurally conserved regions (underlined residues in 
Fig. 2) of coCgTx GVIA, CMTI-I, EETI-II and CPI, the 
RMSD was found to be 0.93, 1.35, 1.01 and 0.82 A, respec-
tively. 
The core of the P-sheets XXC2, XC5X, XXC6X, is not 
recognizable from sequence alone, but the spacing between 
the six cysteine residues is also important. The following spac-
ing consensus of cysteine residues is found in inhibitor pro-
teins: CX3-7CX4-6CX0-5CX1^1CX4-10C, including AVR9. 
The ring formed by connecting C1-C4 and C2-C5 consists of 
eight residues in kalata B, nine in CPI and AVR9, 11 in 
CMTI-I and EETI-II and 12 in coCgTx GVIA, respectively 
B 
Fig. 3. 3D structures of AVR9 (A) as determined by DG-II and CPI (B) as determined by X-ray crystallography, with the three anti-parallel 
strands forming the P-pleated sheet. The cystine bridges are indicated. 
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[25]. The disulfides C2-C5 and C3-C6 superimpose very well 
in all inhibitor cystine knots including AVR9, and are thus 
most conserved. The C1-C4 bridge is only poorly superimpos-
able in all proteins and seems to play a minor role in folding 
as has been determined for EETI-II [42]. 
Structurally AVR9 is most related to CPI. AVR9 and CPI 
can be aligned over a large sequence region from Y6-C11 and 
from C21-H33. The RMSD of alignment of the backbone 
atoms (19 residues representing 152 atoms) of the two pro-
teins over this region is 1.22 A (Fig. 3). In CPI the C-terminal 
residues YVG are involved in binding to carboxypeptidase. 
For AVR9 the residues involved in binding to a plant receptor 
are not known yet. Recent studies by Vogelsang et al. (un-
published results) showed that exchanging residues R13 or 
R23 in AVR9 by K increased biological activity in Cf-9 to-
mato genotypes, exchanging residue L29 by S abolished bio-
logical activity, while exchanges of selected other amino acids 
had no or intermediate effects on biological activity. The loop 
residues PRILM of the trypsin inhibitors CMTI-I and EETI-
II are involved in binding to trypsin. The basic R residue and 
the hydrophobic M residue are most crucial for binding. This 
PRILM loop is clearly not present in AVR9 nor CPI (Fig. 2). 
On the other hand the carboxypeptidase-binding loop of CPI 
(especially the C terminal residues YVG) is not present in 
AVR9. It would be interesting to construct a chimeric protein 
starting from the AVR9 backbone which has both trypsin and 
carboxypeptidase inhibiting activity by adding the PRILM 
and YVG residues. Such a bis-headed inhibitor has been cre-
ated by Chiche et al. [43] by adding the amino acid residues 
YVG (present at the C-teminus of CPI) to the C-terminus of 
EETI-II. In this way they created a protein inhibitory to both 
trypsin and carboxypeptidase. 
Whereas of most of the proteins discussed, the (intrinsic) 
biological activity is known, from the fungal AVR9 protein it 
is only known that it induces a fast HR in plant carrying the 
disease resistance gene Cf-9. The function of AVR9 for the 
fungus C. fulvum itself is yet unknown. Homologies between 
the promoter of the Avr9 gene and the promoter of genes 
involved in nitrogen metabolism of A. nidulans and Neuro-
spora crassa along with its induction under low nitrogen con-
ditions [44,45] suggest that AVR9 might be involved in nitro-
gen metabolism [23]. For the induction of HR in Cf9 
genotypes of tomato the C-terminal 28 amino acids of 
AVR9 are sufficient. Based on the structure presented in 
this paper, the five N-terminal amino acids of the 33 amino 
acid elicitor show no secondary structure and are therefore 
probably easily processed by plant and or fungal proteases. 
Complete reduction of the AVR9 protein abolishes HR induc-
ing activity, indicating that secondary structure is required for 
biological activity. As AVR9 only induces HR in tomato 
plants carrying the Cf-9 resistance gene it is tempting to spec-
ulate on the possibility that the Cf-9 resistance gene product 
binds to AVR9. In tomato plants a binding site for AVR9 has 
been reported, but it is yet uncertain whether this binding site 
is the product of the Cf-9 gene itself, one of his homologs, or 
a receptor that is closely associated with the product of the 
Cf-9 gene [46]. 
Growth factors such as transforming growth factor-(32, 
nerve growth factor, and platelet derived growth factor-BB 
also belong to the growth factor cystine knots [40] They 
also contain three disulfides and antiparallel [J-sheets, but 
the motifs are topologically different and cannot be superim-
posed. In growth factors the ring is formed by cysteine resi-
dues C2-C5 and C3-C6, through which the the disulfide bond 
C1-C4 penetrates. The ring varies between eight and 15 res-
idues. The growth factors are able to form dimers either non-
covalenty (nerve growth factor), by one intermolecular disul-
fide bond (transforming growth factor) or by two intermolec-
ular disulfide bonds (platelet-derived growth factor). Dimer-
isation is required before binding to receptors can occur. Of 
the inhibitor cystine knot proteins described, it not is known 
whether they dimerize before binding to their receptor. In 
solution dimerization has not been observed, but this does 
not exclude that it could occur in vivo where redox conditions 
could favour disulfide formation [47]. If AVR9 would form 
dimers through disulfide bonds under certain conditions the 
C1-C4 disulfide bond (i.e. the C7-C21 disulfide bond) would 
probably be reduced most easily and would be available for 
intermolecular dimerization. This is the topic of our current 
research. 
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